Navigation Links
Delaying post-surgical radiation increases risk of breast cancer recurrence in older women
Date:3/3/2010

BOSTON--Older women who have had breast cancer surgery have a greater risk of the cancer returning if they delay their post-surgical radiation treatment, report Dana-Farber Cancer Institute scientists.

The study, which involved more than 18,000 women age 65 and older who had breast cancer, found that those who started radiation treatment more than six weeks after breast-conserving surgery were more likely to have a local recurrence than those whose radiation treatment started within six weeks of surgery. The findings are being published online by the British Medical Journal.

Rinaa Punglia, MD, MPH, a radiation oncologist at Dana-Farber and Brigham and Women's Hospital and the study's lead author, said she and her colleagues conducted the research to address scientifically the debate about the "appropriate interval between surgery and radiation treatment, or radiotherapy, and its impact on treatment outcomes."

Post-surgical radiotherapy is designed to destroy remaining cancer cells following the removal of a localized breast tumor. Punglia said four to six weeks after surgery is widely viewed as a safe interval for beginning radiotherapy, which typically is administered five days a week for six weeks.

The researchers reviewed Medicare database records of 18,050 women with early stage breast cancer to assess whether the timing of when radiotherapy started following surgery affected outcomes. These women were treated between 1991 and 2002 with lumpectomy and radiation, but not chemotherapy. Thirty percent of women began radiotherapy six or more weeks after surgery.

For the overall group, slightly more than 4 percent of the women experienced a local recurrence. The risk increased to about 5 percent, approximately a 19 percent jump, when the surgery-radiotherapy interval was longer than six weeks. The researchers found that there was no "threshold" at which the risk suddenly rose it increased incrementally day by day. "There isn't a large difference between 43 days instead of 41," commented Punglia. "The day-to-day risk increase is very small."

The rise in breast-conserving surgery in the past two decades has fueled greater demand for radiotherapy, and might be one cause of longer waiting times. The study revealed more delays in areas such as the Northeast, where the procedure is more common, and fewer delays in the southern states, where breast-conserving surgery is less common.

Waiting times were also longer in cases involving African-American and low-income women, but the study did not pinpoint the exact source of the delay. "It could be factors such as access to care, the patients' ability to navigate the healthcare system, or physician referrals," said Punglia.

Although the study focused on older women, the findings have implications for younger women.

"It's possible that the increased risk we identified in older women could be magnified in younger women, whose tumors are biologically different and tend to be more aggressive," said Punglia, who is also an assistant professor of radiation oncology at Harvard Medical School.


'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Related medicine news :

1. Excessive overtriage in US trauma centers overwhelming system resources, delaying patient care
2. Delaying school start time by one hour positively affects adolescents cognitive performance
3. Study: Delaying evolution of drug resistance in malaria parasite possible
4. Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer
5. Safety of Labor-Delaying Drugs Questioned
6. Avastin effective at delaying brain tumor progression in recurrent disease
7. Risks of Delaying ACL Reconstruction in Young Athletes May Be Too High, Study Shows
8. Delaying Health Care Reform is U-N-A-C-C-E-P-T-A-B-L-E!
9. U.S. Women Delaying Motherhood, Report Shows
10. Delaying Weight-Loss Surgery May Leave Teens at Risk
11. New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... will spark a conversation on the current obstacles facing infection prevention and offer ... preventable deaths caused by these infections. , The print component of “Fighting ...
(Date:3/24/2017)... ... March 24, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased ... Huebner Road. The clinic is the group’s 7th location in San Antonio and 23rd ... PT, will provide care from the clinic, which opened March 22, 2017. ...
(Date:3/24/2017)... ... 2017 , ... As the standards bearer of advanced cancer ... positions them as the go-to thought leader in all matters concerning oncology nursing. ... always-on, always-fresh news, views and advocacy engine, called ONS Voice. , The ONS ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... ... 2017 , ... “Vintage and Harvest A Cultivation of Christian Love” is the ... in North Carolina with his wife, Anna Marie. He and his wife are the ... is also the author of “Shadow and Substance.” , “Love, the agape kind, is ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017  Zymo Research Corp., also known ... Inc., who designs, manufactures and distributes liquid ... teams Zymo Research,s DNA methylation detection and ... products with Hamilton,s high-throughput automation platforms. Zymo ... microbiomics and RNA isolation for use on ...
(Date:3/24/2017)... , March 24, 2017   The ... organization within medical affairs in the pharmaceutical industry ... the chair of a newly formed scientific advisory ... members to form the first ever medical affairs ... For more information about the ACMA, please visit  ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
Breaking Medicine Technology: